Head-to-head · Cost-Efficiency Index
Queen RX vs Goldspan Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Queen RX
Cost-first shoppers who want a low one-time cost to try a GLP-1 without committing to a monthly subscription.
Visit Queen RXGoldspan Health
Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.
Visit Goldspan HealthThe verdict
Queen RX and Goldspan Health tie on the Cost-Efficiency Index at 71/100, so neither wins outright on the numbers. For most shoppers we'd start with Queen RX (ranked #75, a hair above #77) — Cost-first shoppers who want a low one-time cost to try a GLP-1 without committing to a monthly subscription. But Goldspan Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Queen RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Queen RX | Goldspan Health |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 71/100 |
| Semaglutide / mo | $100/mo (starting dose, bundle, compounded) | $229 every 28 days month-to-month (13 charges a year, not 12) |
| Tirzepatide / mo | $100/mo (bundle, compounded) | $299 every 28 days month-to-month (13 charges a year, not 12) |
| Semaglutide / yr (modeled) | $1,200 | $2,748 |
| Tirzepatide / yr (modeled) | $1,200 | $3,588 |
| Coverage | 45 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #75 | #77 |
Queen RX
71/100Where the value is
- Full refund if the physician determines you can't be prescribed anything
- No subscription or membership fee — a single $299 purchase covers a full 3-month course including supplies
- Works out to one of the lower per-month equivalents in this batch when averaged over the 3-month term
The tradeoffs
- Not actually a monthly price — it's a one-time $299 purchase per 3-month term; there is no month-to-month billing option at all
- No price differentiation between semaglutide, tirzepatide, and liraglutide — all fall under the same $299 bundle regardless of which drug is prescribed or its dose
Goldspan Health
71/100Where the value is
- Prices ten separate GLP-1 products openly — injection and sublingual, standard and low dose, with a B12 or a glycine base — before any account
- Each plan card itemizes what the figure buys: the clinician evaluation, the medication, injection supplies, two-day shipping and clinical-team access
- States the billing cycle honestly on the plan card and the order timeline as 28 days and four weeks
The tradeoffs
- The hero prints "/month" over a plan billed every 28 days, which is 13 charges a year rather than 12
- "Pause, delay, or cancel at any time" sits against a refund policy reading "all sales are final" and storefront terms saying an order cannot be canceled once placed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.